Abstracts Of Interest At The 78th Ada Scientific Sessions | Latest News RSS feed

Abstracts Of Interest At The 78th Ada Scientific Sessions - Latest News


Abstracts of Interest at the 78th ADA Scientific Sessions

ADA 2018 abstracts of interest include Entresto for the Treatment of Diabetic Peripheral Neuropathy; Oral Contraceptive Associated with Postmenopausal Diabetes; Glucokinase as Adjunct Therapy in Peopl... read more

New Late-Breaking Data at ADA Underscore Significant Benefits of Abbott's FreeStyle Libre System for People Living with Diabetes

Presented at the American Diabetes Association 78th Scientific Sessions. https://plan.core-apps.com/tristar_ada18/abstract/5188446740e191fd289345d56a7d4359 4 Hellmund, Richard. Cost Calculation and Ad... read more

Zealand Pharma presents two dasiglucagon milestone studies at the 78th Scientific Sessions of the American Diabetes Association (ADA)

2018 - Zealand Pharma ("Zealand") announces today that results from two studies on dasiglucagon will be presented at the 78th Scientific Sessions of the American Diabetes Association (ADA) in Orlando, ... read more

Looking for another news?


Lexicon Pharmaceuticals : to Present New Clinical Data at 78th American Diabetes Association Scientific Sessions

LXRX), today announced that new clinical data for sotagliflozin will be presented at the upcoming 78th American Diabetes Association (ADA) Scientific Sessions in Orlando, FL, from June 22-26. The four ... read more


IBM Watson Health Showcases Health Technology Advancements at American Diabetes Association's 78th Scientific Sessions

as presented at the American Diabetes Association's (ADA) 78th Scientific Sessions. Through IBM Watson Health's ongoing partnership with Medtronic, the companies announced the commercial availability ... read more

Poster Summaries of Interest at the 78th ADA Scientific Sessions

Key ADA poster summaries include liraglutide in type 1 diabetes, oral semaglutide, bottled water’s association with type 2 diabetes, & SGLT-2 combo LIK066. ADA: Liraglutide in Type 1 Diabetes In a 52- ... read more

Lexicon to present new clinical data for sotagliflozin at 78th ADA scientific sessions

Lexicon Pharmaceuticals, Inc has announced that new clinical data for sotagliflozin will be presented at the upcoming 78th American Diabetes Association (ADA) scientific sessions in Orlando, FL, from ... read more

New Imeglimin Data Demonstrating Pancreatic Beta-Cell Protection Presented at the American Diabetes Association 78th Scientific Sessions

The abstract titled, “Imeglimin Protects Ins-1 Cells and Human Islets Against High Glucose and High Fructose-induced Cell Death by Inhibiting the Mitochondrial PTP Opening” was presented in a scientif... read more

Insulet : to Unveil New Omnipod® DASHTM System and Present Innovative Research at the American Diabetes Association's 78th Scientific Sessions

78th Scientific Sessions at the Orange County Convention Center in Orlando, Florida June 22-25, 2018. Insulet will also have a robust clinical presence at the meeting with 10 accepted abstracts, inclu... read more

AstraZeneca to present 45 abstracts from CVRM therapy area at ADA 2018

will present 45 abstracts including seven late-breaking data disclosures from the company's cardiovascular, renal & metabolism (CVRM) therapy area at the American Diabetes Associations (ADA) 78th Scie... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us